Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

DE GROOT, JOHN FREDERICK

One or more keywords matched the following items that are connected to DE GROOT, JOHN FREDERICK

Item Type	Name
Academic Article	Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma.
Concept	Angiogenesis Inhibitors
Academic Article	Update on anti-angiogenic treatment for malignant gliomas.
Academic Article	Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.
Academic Article	Bevacizumab and irinotecan in the treatment of recurrent malignant gliomas.
Academic Article	Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition.
Academic Article	Neutrophils promote the malignant glioma phenotype through S100A4.
Academic Article	Resistance to antiangiogenic therapy.
Academic Article	VEGF Trap induces antiglioma effect at different stages of disease.
Academic Article	Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
Academic Article	High-dose antiangiogenic therapy for glioblastoma: less may be more?
Academic Article	Antiangiogenic therapy for glioblastoma: the challenge of translating response rate into efficacy.
Academic Article	Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumab.
Academic Article	Antiangiogenic therapy for glioblastoma: current status and future prospects.
Academic Article	Interferon-regulatory factor-1 (IRF1) regulates bevacizumab induced autophagy.
Academic Article	Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models.
Academic Article	Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials.
Academic Article	Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy.
Academic Article	Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy.
Academic Article	Treatment of Glioblastoma.
Academic Article	Lower-grade gliomas: the wrong target for bevacizumab.
Academic Article	A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).
Academic Article	Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival.

Search Criteria

Angiogenesis Inhibitors